← Leaderboards
Nicole Faron Liachko
Va Puget Sound Healthcare System
$2,745,815
Attributed
$2,745,815
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $663K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,745,815 · 2
VA$0 · 4
By mechanism
R01$2,612,954 · 1
P30$132,861 · 1
I01$0 · 2
IK2$0 · 1
IS1$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va Puget Sound Healthcare System
Same institution · by research overlap
- Brian C. Kraemer$19,537,143
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAmyotrophic Lateral SclerosisProteinsGenesNeuronsTherapeutic InterventionAffectPathologyCaenorhabditis ElegansNew Therapeutic TargetNerve DegenerationNeurodegenerative DisordersResponseProtein Tdp-43NeurotoxicityBrainMutationDementiaTherapeutic DevelopmentPathway InteractionsGeneticIn VivoPathologicNeuronal Dysfunction
Grant awards (19)
TDP-43 in Alzheimer's disease$501,206
R01 · FY2025 · AG · contact PI
Mechanisms of TDP-43 neurotoxicity in Alzheimer's disease$0
I01 · FY2025 · VA · contact PI
TDP-43 in Alzheimer's disease$530,161
R01 · FY2024 · AG · contact PI
CELLULAR AND MOLECULAR IMAGING CORE$132,861
P30 · FY2024 · DK · contact PI
Mechanisms of TDP-43 neurotoxicity in Alzheimer's disease$0
I01 · FY2024 · VA · contact PI
TDP-43 in Alzheimer's disease$530,161
R01 · FY2023 · AG · contact PI
Mechanisms of TDP-43 neurotoxicity in Alzheimer's disease$0
I01 · FY2023 · VA · contact PI
TDP-43 in Alzheimer's disease$531,273
R01 · FY2022 · AG · contact PI
ShEEP request for Andor Dragonfly High Speed Confocal Platform$0
IS1 · FY2022 · VA · contact PI
Investigating calcineurin regulation of pathological TDP-43 phosphorylation in ALS$0
I01 · FY2022 · VA · contact PI
TDP-43 in Alzheimer's disease$520,153
R01 · FY2021 · AG · contact PI
Investigating calcineurin regulation of pathological TDP-43 phosphorylation in ALS$0
I01 · FY2021 · VA · contact PI
Investigating calcineurin regulation of pathological TDP-43 phosphorylation in ALS$0
I01 · FY2020 · VA · contact PI
Investigating calcineurin regulation of pathological TDP-43 phosphorylation in ALS$0
I01 · FY2019 · VA · contact PI
Investigation of modifiers of TDP-43 neurotoxicity in ALS models$0
IK2 · FY2018 · VA · contact PI
Investigation of modifiers of TDP-43 neurotoxicity in ALS models$0
IK2 · FY2017 · VA · contact PI
Investigation of modifiers of TDP-43 neurotoxicity in ALS models$0
IK2 · FY2016 · VA · contact PI
Investigation of modifiers of TDP-43 neurotoxicity in ALS models$0
IK2 · FY2015 · VA · contact PI
Investigation of modifiers of TDP-43 neurotoxicity in ALS models$0
IK2 · FY2014 · VA · contact PI